期刊文献+

金雀异黄素对Ⅱ型胶原诱导性关节炎大鼠血清骨保护素及核因子-κB受体活化因子配体的影响 被引量:1

原文传递
导出
摘要 目的:研究金雀异黄素(genistein,Gen)对Ⅱ型胶原诱导性关节炎模型(typeⅡ,CIA)大鼠血清骨保护素(OPG)及核因子-κB 受体活化因子配体(RANKL)的影响。方法采用 SPSS 17.0软件随机抽样分为两组,编号1~10为空白对照组、11~60为造模组。造模组的50只大鼠建立CIA模型。造模成功的大鼠再按上述编号分为模型对照组、低剂量Gen组、中剂量Gen组、高剂量Gen组和甲氨蝶呤(MTX)组,于造模次日开始用药,各Gen组灌胃Gen混悬液1 ml/d;甲氨蝶呤组每周灌胃MTX 1 ml/次,浓度为0.1 mg/ml;空白组、模型对照组每天灌胃等量的生理盐水。用酶联免疫吸附试验(ELISA)检测各组大鼠血清RANKL及OPG的水平。结果骨代谢因子RANKL在模型对照组大鼠血清中表达量(0.328±0.044)的显著高于空白对照组(0.180±0.029)(P<0.05);Gen中、高剂量对RNAKL的抑制作用(分别为0.144±0.017、0.163±0.020)与甲氨蝶呤组(0.139±0.072)相当。模型对照组大鼠血清中的细胞因子OPG的表达水平(0.103±0.013)低于空白对照组(0.268±0.022)(P<0.05);Gen中、高剂量对OPG(分别为0.149±0.012、0.145±0.024)的上调作用与甲氨蝶呤组(0.160±0.056)相当。结论 Gen可影响 CIA 大鼠血清中 RANKL、OPG 水平,从而影响 OPG/RANKL 比值。提示 Gen 可能通过RANKL/OPG/RNAK通路抑制RA骨质破坏。 Objective To explore the effects of genistein(Gen) on OPG/RANKL in the serum of Collagen-induced arthritis(CIA) rats. Methods Sixty Sprague-Dawley rats were randomly divided into six groups, with 10 rats in each group respectively, normal group, model group, low-dose Gen treatment group, moderate-dose Gen treatment group, high-dose Gen treatment group and methotrexate group. The levels of OPG and RANKL were determined by ELISA. Results The level of RANKL serum was significantly higher in the model group (0.328±0.044) that in control group(0.328±0.044), P〈0.05. Moderate-dose Gen treatment group and high-dose Gen treatment group can down-regulate of RANKL(0.144±0.017, 0.163±0.020)respectively. The level of OPG in the model group(0.103±0.013) was the lower than that in the control group(0.268±0.022), P〈0.05. Gen treatment group and high-dose Gen treatment group can up-regulation of OPG(0.149±0.012, 0.145±0.024)respectively. Conclusion The Gen can enhance the OPG/RANKL ratio for the CIA rats, which may exert their inhibitory effect of RA bone destruction.
出处 《国际中医中药杂志》 2014年第8期711-714,共4页 International Journal of Traditional Chinese Medicine
  • 相关文献

参考文献13

  • 1Calmon-Hamaty F, Combe B, Hahne M, et al. Lymphotoxin-a stimulates proliferation and pro-inflammatory cytokine secretion of rheumatoid arthritis synovial fibroblasts [J]. Cytokine, 2011, 53 (2): 207-214.
  • 2Lee SW, Kim JH, Park MC, et al. Alleviation of rheumatoid arthritis by cell-transducible methotrexate upon transcutaneous delivery[J].Biomaterials, 2012, 33 (5): 1563-1572.
  • 3Neumann E, Lefevre S, Zimmermann B, et al. Rheumatoid arthritis progression mediated by activated synovial fibroblasts[J]. Trends Mol Med, 2010, 16 (10): 458-468.
  • 4Allaire S, Wolfe F, Niu J, et al. Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US [J]. Arthritis Rheumatism, 2008, 59 (4): 474-480.
  • 5AndoK, MoriK, RediniF, etal. RANKL/R.ANK/OPG: key therapeutic target in bone oncology[J]. Curr Drug Discov Technol, 2008, 5 (3): 263-268.
  • 6Zhao R, Xiang N, Domann FE, et al. Effects of selenite and genistcin on G2/M cell cycle arrest and apoptosis in human prostate cancer cells [J]. Nulr cancer, 2009, 61 (3): 397-407.
  • 7Reiter E, Reiter E, Beck V, et al. Isofiavones am safe compounds for therapeutical applications-evaluation of in vitro data[J]. GynecolEndecrinol, 2009, 7 (7): 1-27.
  • 8高波,张育,马莉,张学增.金雀异黄素对Ⅱ型胶原诱导型关节炎大鼠成纤维样滑膜细胞分泌白细胞介素1β和肿瘤坏死因子α的影响[J].中西医结合学报,2009,7(7):636-641. 被引量:8
  • 9Yao Y, Ding CZ, Fang Y. Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats [J]. Rheumatol Int, 2013, 33 (7): 1845-1853.
  • 10Geusens P. The role of RANK ligand/osteoprotegerin in rheumatoid arthritis [J]. Ther Adv Musculoskelet Dis, 2012, 8 (4): 225-233.

二级参考文献29

  • 1王守英,李志春,卜勇军.大豆异黄酮的生物学作用研究进展[J].新乡医学院学报,2005,22(4):397-400. 被引量:6
  • 2Fiedorczyk M, Klimiuk PA, Sierakowski S, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis. Pol Merkur Lekarski, 2006, 20: 228.
  • 3Ravindranath MH, Muthugounder S, Presser N, et al. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol, 2004, 546: 121.
  • 4Kim MH. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. Cell Biochem, 2003, 89: 529.
  • 5Barrett JR. The science of soy: what do we really know? Environ Health Perspect, 2006, 114: 352.
  • 6Morales-Ducret J, Wayner E, Elices MJ, et al. Alpha4/betal integrin (VLA-4) ligands in arthritis: vascular cell adhesion molecule-I in synovium and on fibroblast-like synoviocytes. Immunology, 1992, 149: 1424.
  • 7Taylor PC, Sivakumar B. Hypoxia and angiogenesis in rheumatic diseases. Curr Opin Rheumatol, 2005, 17: 293.
  • 8Rundhaug JE. Matrix metalloproteinases and angiogenesis. Cell Mol Med, 2005, 9: 267.
  • 9Giannelli G, Erriquez R, Iannone F, et al. MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis. Clin Exp Rheumatol, 2004, 22: 335.
  • 10Fiedorczyk M, Klimiuk PA, Sierakowski S, et al. Serum matrix metalloproteinases and tissue iuhibitors of metalloproteinases in patients with early rheumatoid arthritis. Rheumatology, 2006, 33: 1523.

共引文献10

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部